Matthew J. Davis
University of Tennessee Health Science Center(US)Kansas State University(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Genomics and Rare Diseases
Most-Cited Works
- → Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma(2012)1,178 cited
- → Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling(2011)994 cited
- → High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing(2011)537 cited
- → Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification(2018)304 cited
- → Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results(2022)211 cited
- → Transcriptional Network of Multiple Capsule and Melanin Genes Governed by theCryptococcus neoformansCyclic AMP Cascade(2005)181 cited
- → RAC1 P29S is a spontaneously activating cancer-associated GTPase(2013)174 cited
- → IFITM 3 requires an amphipathic helix for antiviral activity(2017)121 cited
- → A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results(2024)109 cited
- → Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate(2012)83 cited